184 results on '"Van Der Schoot, Ellen"'
Search Results
2. Natural history of human platelet antigen 1a-alloimmunised pregnancies: a prospective observational cohort study
3. Prospective individual patient data meta-analysis of two randomized trials on convalescent plasma for COVID-19 outpatients
4. Generation of human antibodies targeting human platelet antigen (HPA)-1a
5. Generation of human antibodies targeting human platelet antigen (HPA)‐1a
6. Case series on clinical applications of liquid biopsy in pediatric solid tumors: towards improved diagnostics and disease monitoring
7. P366: ARE MINIMAL RESIDUAL DISEASE MEASUREMENTS AFTER CONSOLIDATION THERAPY USEFUL IN CHILDREN WITH ACUTE LYMPHOBLASTIC LEUKEMIA?
8. Fetal and neonatal alloimmune thrombocytopenia: Current pathophysiological insights and perspectives for future diagnostics and treatment
9. Measurement of post-transfusion red blood cell survival kinetics in sickle cell disease and β-Thalassemia: A biotin label approach
10. International Society of Blood Transfusion Working Party on Red Cell Immunogenetics and Blood Group Terminology Report of Basel and three virtual business meetings: Update on blood group systems
11. Human IgG lacking effector functions demonstrate lower FcRn-binding and reduced transplacental transport
12. Antigen specificity determines anti-red blood cell IgG-Fc alloantibody glycosylation and thereby severity of haemolytic disease of the fetus and newborn
13. Comparison of SARS‐CoV ‐2 neutralizing antibody testing of convalescent plasma donations in the Netherlands and England: A pilot study
14. Frequency and characterization of known and novel RHD variant alleles in 37 782 Dutch D-negative pregnant women
15. Factors contributing to the pathogenesis of IgG-mediated alloimmune disease
16. Minimal residual disease detection in autologous stem cell grafts from patients with high risk neuroblastoma
17. Impact of genetic variation in the SMIM1 gene on Vel expression levels
18. Prophylactic anti-D preparations display variable decreases in Fc-fucosylation of anti-D
19. Novel alleles at the Kell blood group locus that lead to Kell variant phenotype in the Dutch population
20. Dynamics of antibodies to SARS-CoV-2 in convalescent plasma donors
21. Low anti-RhD IgG-Fc-fucosylation in pregnancy: a new variable predicting severity in haemolytic disease of the fetus and newborn
22. Molecular analysis of immunized Jr(a–) or Lan– patients and validation of a high-throughput genotyping assay to screen blood donors for Jr(a–) and Lan– phenotypes
23. H435-containing immunoglobulin G3 allotypes are transported efficiently across the human placenta: implications for alloantibody-mediated diseases of the newborn
24. Minimal residual disease diagnostics in acute lymphoblastic leukaemia: impact of primer characteristics and size of junctional regions
25. Dynamics of antibodies to SARS-CoV-2 in convalescent plasma donors
26. Comprehensive genotyping for 18 blood group systems using a multiplex ligation-dependent probe amplification assay shows a high degree of accuracy
27. Noninvasive prenatal blood group and HPA-1a genotyping: the current European experience
28. BIGH3 modulates adhesion and migration of hematopoietic stem and progenitor cells
29. RHD and RHCE variant and zygosity genotyping via multiplex ligation–dependent probe amplification
30. Confirmed non‐invasive prenatal testing for foetal Rh blood group genotyping along with bi‐allelic short insertion/deletion polymorphisms as a positive internal control.
31. Relevance of the JAK2V617F mutation in patients with deep vein thrombosis of the leg
32. Molecular analysis of the York antigen of the Knops blood group system
33. Divergent SARS‐CoV‐2‐specific T‐ and B‐cell responses in severe but not mild COVID‐19 patients
34. Divergent SARS-CoV-2-specific T and B cell responses in severe but not mild COVID-19
35. Abstract A53: Hypermethylated RASSF1A as circulating tumor marker in pediatric and adolescent solid tumors
36. Abstract B56: Neuroblastoma patient-derived tumor-specific mRNA and DNA in platelets and extracellular vesicles
37. Cell cycle and tissue of origin contribute to the migratory behaviour of human fetal and adult mesenchymal stromal cells
38. Extended phenotyping does not preclude the occurrence of delayed haemolytic transfusion reactions in sickle cell disease.
39. SAFE—The Special Non-invasive Advances in Fetal and Neonatal Evaluation Network: aims and achievements
40. Workshop report on the extraction of foetal DNA from maternal plasma
41. The BloodGen project: toward mass-scale comprehensive genotyping of blood donors in the European Union and beyond
42. Testing for weak D
43. Diary of events
44. A proinflammatory monocyte response is associated with myocardial injury and impaired functional outcome in patients with ST-segment elevation myocardial infarction: Monocytes and myocardial infarction
45. CD antigens 2001
46. Genetic determinants of ferritin, haemoglobin levels and haemoglobin trajectories: results from Donor InSight.
47. Performance evaluation study of ID CORE XT, a high throughput blood group genotyping platform
48. CD Antigens 2001
49. Triple immunofluorescence staining for prediction of relapse in childhood precursor B acute lymphoblastic leukaemia
50. Consensus strategy to quantitate malignant cells in myeloma patients is validated in a multicenter study
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.